Insider Transaction Report for Melinda Litherland

Melinda Litherland, a director at BIO-RAD LABORATORIES, INC., acquired 407 shares of Bio-Rad A Common Stock on April 21, 2026, upon the vesting of restricted stock units. The shares were acquired at a price of $0.0 per share, resulting in a post-transaction ownership of 715 shares. Additionally, Ms. Litherland was involved in a transaction where 407 restricted stock units were disposed of, with each unit representing a contingent right to one share of Bio-Rad Class A common stock. These units were set to vest fully on the earlier of the first anniversary of the grant date or the company's next annual meeting. The reported transactions indicate a net acquisition of shares following the vesting of equity awards.